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Abstract—Objective: To assess whether the quality of reporting of diagnostic accuracy studies has improved since the
publication of the Standards for the Reporting of Diagnostic Accuracy studies (STARD statement).Methods: The quality of
reporting of diagnostic accuracy studies published in 12 medical journals in 2000 (pre-STARD) and 2004 (post-STARD)
was evaluated by two reviewers independently. For each article, the number of reported STARD items was counted (range
0 to 25). Differences in completeness of reporting between articles published in 2000 and 2004 were analyzed, using
multilevel analyses. Results: We included 124 articles published in 2000 and 141 articles published in 2004. Mean number
of reported STARD items was 11.9 (range 3.5 to 19.5) in 2000 and 13.6 (range 4.0 to 21.0) in 2004, an increase of 1.81
items (95% CI: 0.61 to 3.01). Articles published in 2004 reported the following significantly more often: methods for
calculating test reproducibility of the index test (16% vs 35%); distribution of the severity of disease and other diagnoses
(23% vs 53%); estimates of variability of diagnostic accuracy between subgroups (39% vs 60%); and a flow diagram (2% vs
12%). Conclusions: The quality of reporting of diagnostic accuracy studies has improved slightly over time, without a more
pronounced effect in journals that adopted the STARD statement. As there is still room for improvement, editors should
mention the use of the STARD statement as a requirement in their guidelines for authors, and instruct reviewers to check
the STARD items. Authors should include a flow diagram in their manuscript.
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Many authors have emphasized the poor quality of
research reports, which hampers an adequate judg-
ment of the validity of a study.1-3 Several groups
have developed guidelines to improve the reporting
of randomized controlled trials (CONSORT), diag-
nostic accuracy studies (STARD), observational stud-
ies (STROBE), systematic reviews of randomized
controlled trials (QUOROM), and of observational
studies (MOOSE).4-11
In January 2003, Standards for the Reporting of
Diagnostic Accuracy studies (STARD statement)
were published simultaneously in eight medical jour-
nals.7,8 The STARD statement contains a checklist of
25 recommended items and encourages the use of a
flow diagram to represent the design of the study
and the flow of patients through the study.7,8
Many authors have evaluated the quality of re-
porting of diagnostic accuracy studies published be-
fore 2003 with the STARD checklist.12-14 The quality
of reporting varied from 6% for reporting the esti-
mates of test reproducibility to 100% for discussion
of the clinical applicability and research question.12,14
Two studies found that around 40% of the studies
reported on more than half of the STARD items.12,14
Our main objective is to examine whether the
quality of reporting in diagnostic accuracy studies
was improved since the publication of the STARD
statement. Therefore we compared the quality of re-
porting of diagnostic accuracy studies published in
journals with an impact factor of at least 4, before (in
2000)12 and after (in 2004) the publication of the
STARD statement. In addition, we compare the im-
provement in the quality of reporting in studies pub-
lished in journals adopting the STARD statement vs
non-adopting journals.
Methods. Data sources. One reviewer (N.S.) searched MED-
LINE and used a validated strategy ([Sensitivity AND specifici-
ty.sh] OR [Specificit*.tw] OR [False negative.tw] OR
[Accuracy.tw])15 to identify articles on diagnostic accuracy pub-
lished in six general medical journals (Annals of Internal Medi-
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cine, Archives of Internal Medicine, BMJ, JAMA, Lancet, New
England Journal of Medicine) and six disease-specific or
discipline-specific journals (Archives of Neurology, Clinical Chem-
istry, Circulation, Gut, Neurology, Radiology). The selection of
these journals was based on the number of diagnostic accuracy
studies published in 2000 and their impact factor (4).12 The
search was limited to studies focusing on human subjects and
articles published in 2000 and 2004.
Study selection. Articles were included if 1) they were pub-
lished in 2000 or 2004 in one of the 12 selected journals, 2) they
concern diagnostic test research, 3) they were a primary study of
diagnostic accuracy, in which the results of one or more tests were
compared with the findings obtained with a reference standard, 4)
they investigated a clinical population (no healthy volunteers or
animals). Letters, editorials, abstracts, or technical briefs were
excluded. Two reviewers (N.S., A.R.) independently assessed the
title, abstract, and keywords of all potentially eligible articles, to
determine whether they met the inclusion criteria. If there was
any doubt, the full text of the article was retrieved, and read by
both reviewers. Disagreements were discussed and resolved in a
consensus meeting.
Data extraction. The 25 items of the STARD statement were
used to assess the quality of reporting.7,8 For this assessment, the
reviewers had to determine whether each item of the checklist
was adequately described in the text. Reviewers were not expected
to evaluate the likelihood of bias but only the quality of reporting.
The evaluation of the quality of reporting of diagnostic accu-
racy studies published in 2000 was carried out in spring 2003
(between March 2003 and May 2003). Between October 2004 and
March 2005 the quality of reporting of studies published in 2004
was assessed. Two reviewers independently evaluated the in-
cluded articles. Note that the reviewers were not blinded to the
source (year of publication, journal, authors) of the articles. One
reviewer (N.S.) assessed all articles and four other reviewers
(A.R., H.V., D.W., and R.O.) each evaluated one fourth of all the
articles published in 2000 and 2004. Disagreements between two
reviewers were discussed and resolved in a meeting. If consensus
could not be reached, a third reviewer made the final decision.
Statistical analysis. For each item in the STARD statement,
the total number of articles reporting the elements mentioned in
that item was calculated for 2000 and 2004. For each article, the
total number of reported STARD items was counted (range 0 to
25), as indication of the quality of reporting. As six items (items 8,
9, 10, 11, 13, 24) concern the index test(s) as well as the reference
standard, we counted the index test as ½ item and the reference
standard as ½ item. The overall mean and SD of the total number
of reported STARD items are presented.
Differences in reporting between studies published in 2000 and
2004 were analyzed for each item using logistic multilevel analy-
ses, taking journal level effects into account. Using a linear multi-
level analysis, differences in the number of reported STARD items
between studies published in 2000 and 2004 were calculated. We
also determined the effects of the use of the STARD statement in
the editorial process of journals (adopters) on the quality of report-
ing of the individual items and on the total number of reported
STARD items. In addition, the influence of the design (case con-
trol vs cohort) on the improvement in the quality of reporting was
assessed.
p Values less than 0.05 were considered significant. Data entry
using SPSS for Windows (Release 11.0.1, 2001) and statistical
analysis using MLwiN (1.10, 2001) were done by N.S.
Results. Search and selection. Figure 1 presents the
search and selection process of diagnostic accuracy studies
published in 2000 and 2004 in the journals at issue. In
these 12 journals, the search strategy identified 884 hits in
2000 and 646 hits in 2004. Based on the title, abstract, and
keywords, a total of 508 articles were independently se-
lected by two reviewers (N.S., A.R.). As a large number of
articles were published in Radiology, we decided to limit
the number of articles in this journal to one fourth of the
total number of potentially eligible publications in Radiol-
ogy, which resulted in 25 articles for 2000 and 27 for 2004.
All potentially eligible articles published in Radiology were
ranked according their publication date. Subsequently, at
least two articles were selected randomly from each
month. Two independent reviewers read the full text of the
351 articles and excluded 86 articles for the following rea-
sons: no diagnostic test research (n  43), lack of reference
standard (n  4), no clinical population (n  22), no full
text article, but a letter to the Editor or technical brief
(n  17). In total, 124 articles published in 2000 and 141
articles published in 2004 were included.
Article characteristics. The percentage cohort studies
and case control studies published in 2000 and 2004 were
Figure 1. Flow diagram of search and selection process of
diagnostic accuracy articles published in 2000 and 2004.
*Due to large number of articles published in Radiology
(n  102 in 2000 and n  108 in 2004), the assessment of
the full text articles published in this journal was limited
to one fourth of the total number of potentially eligible
publications in Radiology (n  25 in 2000 and n  28
in 2004).
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similar (table 1). Seventy-three percent (91/124) of the di-
agnostic articles published in 2000 were cohort studies,
including five reporting on population screening. From the
124 studies that were published in 2004, 96 (68%) were
cohort studies with 14 studies concerning screening in the
general population.
Most diagnostic accuracy articles had been published in
disease-specific or discipline-specific journals, such as Cir-
culation, Clinical Chemistry, Neurology, and Radiology.
In most studies, the diagnostic accuracy of one or more
imaging tests (56%) or laboratory tests (35%) were exam-
ined. In less than 10% of the studies, the diagnostic value
of history taking, questionnaires, or physical examination
was investigated.
Journal characteristics. After the publication of the
STARD statement in January 2003, the Annals of Internal
Medicine, BMJ, Clinical Chemistry, JAMA, The Lancet,
Neurology, and Radiology mentioned the STARD state-
ment in their instructions for authors. These journals were
considered as adopting journals. Although all adopting
journals advise their authors to follow the STARD guide-
lines, there was a broad variation in the clearness and
strictness in the language of their expectations. For exam-
ple, Neurology requires authors to submit a checklist (for
review purposes) and a flow diagram (for publication if the
article is accepted),16 whereas the Lancet only states that
studies of diagnostic accuracy should be reported according
to STARD guidelines.
The other journals did not mention the STARD state-
ment in their instructions for authors and were therefore
considered as non-adopting journals. In the summer of
2004, Gut joined the BMJ Publishing Group and subse-
quently changed their guidelines for authors and adopted
the STARD statement. As the statement had not been
used in the editorial process of articles published in 2004
(personal communication), Gut was considered to be a non-
adopting journal for the current analysis.
Quality of reporting. Reviewing procedure. The inter-
reviewer agreement on the items of the STARD statement
was good (overall agreement 81%, Kappa statistics 0.62).
In 15 articles (6%), disagreements between two reviewers
could not be resolved and the decision was made by one of
the other reviewers. Doubts about identity of the index and
reference test and poor reporting of the design caused most
disagreements. The average time needed to complete the
assessment of the quality of reporting of one article was 47
(range 23 to 83) minutes.
Individual STARD items. The quality of reporting of
the individual items of the STARD statement is presented
in table 2. There was large variation in the quality of
reporting between individual items, varying from 6% (item
24b and item 13b) to 98% (item 25).
The results of the logistic multilevel analysis showed
that seven items were significantly more often reported in
studies published in 2004, including item 4 (OR  4.2 [95%
CI: 1.0 to 17.4]), item 5 (OR  2.75 [95% CI: 1.0 to 7.4]),
item 9a (OR  3.0 [95% CI: 1.3 to 7.0]), item 13a (OR  2.8
[95% CI: 1.5 to 5.0]), item 18a (OR  3.8 [95% CI: 2.2 to
6.5]), item 23 (OR  2.3 [95% CI: 1.4 to 3.8]), and item 25
(OR  4.0 [95% CI: 1.1 to 15.0]).
None of the individual items showed a significant reduc-
tion in the quality of reporting between studies published
in 2000 and 2004.
Total number of reported STARD items. The mean to-
tal number of reported STARD items for articles published
was 11.8 (SD 3.3) in 2000 and 13.6 (SD 3.2) in 2004 (max-
imum is 25). The results of the linear multilevel analysis
confirmed that the quality of reporting of diagnostic accu-
racy studies improved over time. Studies published in 2004
reported on average 1.8 items (95% CI: 0.6 to 3.0) more
Table 1 Number and characteristics of diagnostic accuracy articles published in 2000 and 2004 in 12 medical journals with high
impact factor (4)
Diagnostic accuracy studies
published in 2000 (n  124)
Diagnostic accuracy studies
published in 2004 (n  141)
Journal
Impact
factor*
No. of
articles
Flow
diagram
included
Cohort
(n  91)
Case
control
(n  33)
Impact
factor†
No. of
articles
Flow
diagram
included
Cohort
(n  96)
Case
control
(n  45)
Adopter‡ 78 1 54 24 95 14 61 34
Journal of the American Medical Association 15.4 4 — 4 — 24.8 9 2 8 1
Lancet 10.2 9 — 7 2 21.7 5 2 2 3
Annals of Internal Medicine 9.8 3 — 2 1 13.1 6 5 6 —
British Medical Journal 5.3 2 — 2 — 7.0 3 1 3 —
Neurology 4.8 20 — 8 12 6.0 21 3 9 12
Clinical Chemistry 4.3 15 — 9 6 6.5 24 — 6 18
Radiology 4.1 25 1 22 3 5.1 27 1 27 —
Nonadopter 46 1 37 9 46 3 35 11
New England Journal of Medicine 29.5 7 — 7 — 38.6 3 1 3 —
Circulation 10.9 13 1 11 2 12.6 25 1 19 6
Archives of Internal Medicine 6.1 6 — 4 2 7.5 4 — 4 —
Gut 5.4 13 — 11 2 6.6 7 1 6 1
Archives of Neurology 4.4 7 — 4 3 4.8 7 — 3 4
* Impact factor in 2000 according to www.jcrweb.com.
† Impact factor in 2004 according to www.jcrweb.com.
‡ Adopter of the Standards for the Reporting of Diagnostic Accuracy studies (STARD statement) before January 1, 2004.
794 NEUROLOGY 67 September (1 of 2) 2006
Table 2 Reporting of individual items of the Standards for the Reporting of Diagnostic Accuracy studies (STARD statement) in articles
on diagnostic accuracy published in 2000 and 2004
Item
Articles
published
in 2000
(n  124),
n (%)
Articles
published
in 2004
( n  141),
n (%)
OR
(95% CI)*
Title/abstract/keywords
1 Identify the article as a study of diagnostic accuracy (recommend MeSH heading
“sensitivity and specificity”)
13 (10.5) 26 (18) 1.9 (0.9, 4.0)
Introduction
2 State the research questions or study aims, such as estimating diagnostic accuracy
or comparing accuracy between tests or across participant groups
112 (90) 136 (96.5) Not possible
Methods
3 The study population: The inclusion and exclusion criteria, setting and locations
where data were collected
35 (28) 30 (21) 0.7 (0.3, 1.5)
4 Participant recruitment: Was recruitment based on presenting symptoms, results
from previous tests, or the fact that the participants had received the
index tests or the reference standard?
103 (83) 130 (92) 4.2 (1.0, 17.4)
5 Participant sampling: Was the study population a consecutive series of
participants defined by the selection criteria in item 3 and 4? If not,
specify how participants were further selected
70 (56.5) 108 (77) 2.8 (1.0, 7.4)
6 Data collection: Was data collection planned before the index test and reference
standard were performed (prospective study) or after (retrospective study)?
99 (80) 119 (84) 1.8 (0.6, 5.6)
7 The rationale of the reference standard 70 (56.5) 64 (45) 0.7 (0.4, 1.1)
8 Technical specifications of materials and methods involved including how
and when measurements were taken, or cite references for
a) index tests and 115 (92.5) 137 (97) Not possible
b) reference standard 83 (67) 101 (72) 1.3 (0.7, 2.8)
9 Definition of and rationale for the units, cutoffs, or categories of the results of the
a) index tests and the 103 (83) 132 (94) 3.0 (1.3, 7.0)
b) reference standard 75 (60.5) 102 (72) 1.7 (0.95, 3.1)
10 The number, training, and expertise of the persons executing and reading the
a) index tests and the 51 (41) 72 (51) 2.7 (0.8, 8.4)
b) reference standard 32 (26) 46 (33) 1.6 (0.7, 3.6)
11 Whether or not the readers of the
a) index tests and 46 (37) 55 (39) 1.2 (0.5, 2.6)†
b) reference standard were blind (masked) to the results of the other
test and describe any other clinical information available to the readers
23 (18.5) 39 (28) 1.7 (0.8, 3.5)
12 Methods for calculating or comparing measures of diagnostic accuracy, and the
statistical methods used to quantify uncertainty (e.g., 95% CI)
17 (14) 28 (20) 1.6 (0.6, 3.9)
13 Methods for calculating test reproducibility, if done
a) for the index test 20 (16) 49 (35) 2.8 (1.5, 5.0)
b) for the reference standard 6 (5) 9 (6) 1.3 (0.5, 3.9)
Results
14 When study was performed, including beginning and end dates of recruitment 60 (48) 89 (63) 2.1 (0.9, 4.9)
15 Clinical and demographic characteristics of the study population (at least
information on age, sex, spectrum of presenting symptoms)
65 (52) 84 (60) 1.4 (0.8, 2.4)
16 The number of participants satisfying the criteria for inclusion who did or did
not undergo the index tests and the reference standard; describe why
participants failed to undergo either test (a flow diagram is strongly recommended)
75 (60.5) 83 (59) 0.9 (0.4, 2.1)
17 Time interval between the index tests and the reference standard, and any
treatment administered in between
33 (27) 35 (25) 0.9 (0.5, 1.7)
18 Distribution of severity of disease (define criteria) in those with the target
condition; other diagnoses in participants without the target condition
28 (23) 74 (52.5) 3.8 (2.2, 6.5)
19 A cross tabulation of the results of the index tests (including indeterminate and
missing results) by the results of the reference standard; for continuous results,
the distribution of the test results by the results of the reference standard
104 (84) 124 (88) 1.5 (0.7, 3.3)
20 Any adverse events from performing the index tests or the reference standard 21 (17) 16 (11) 0.6 (0.3, 1.3)
21 Estimates of diagnostic accuracy and measures of statistical uncertainty (e.g., 95% CI) 40 (32) 57 (40) 1.2 (0.5, 2.9)
22 How indeterminate results, missing data, and outliers of the index tests were handled 73 (59) 80 (57) 0.9 (0.5, 1.6)
23 Estimates of variability of diagnostic accuracy between subgroups of participants,
readers, or centers, if done
48 (39) 84 (60) 2.3 (1.4, 3.8)
24 Estimates of test reproducibility, if done
a) index test 40 (32) 62 (44) 1.6 (0.98, 2.7)
b) reference standard 8 (6.5) 8 (6) 0.9 (0.3, 2.4)
Discussion
25 Discuss the clinical applicability of the study findings 114 (92) 138 (98) 4.0 (1.1, 15.0)
* Difference between the quality of reporting of the individual items reported in articles published in 2000 and 2004, adjusted for journal level and esti-
mated with logistic multilevel analysis; OR above 1.0 signifies that an item was more frequently reported in 2004.
† The improvement in quality of reporting item 11A was significantly larger in cohort studies than in case control studies (OR: 0.3 [95% CI; 0.1 to 1.0]).
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than studies published in 2000. In 2004, 62% of the arti-
cles reported on more than half of the 25 items, vs 41% in
2000 (figure 2). None of the articles published in 2000
reported more than 20 of the 25 items, whereas 3 (2%) did
so in 2004.
Flow diagram. Flow diagrams were sparse. Only 2 of
the studies (2%) published in 2000 and 17 (12%) of those
published in 2004 included a flow diagram. Most flow dia-
grams were published in journals that had adopted the
STARD statement (table 1). Studies that included a flow
diagram were associated with higher quality of reporting
(mean difference 1.7 items [95% CI: 0.2 to 3.2]).
Adopting journals vs non-adopting journals. In 2000,
the mean number of items reported in studies published in
adopting and non-adopting journals was 11.9 (SD 3.2) and
12.0 (SD 3.4). In 2004, these numbers were 13.5 (SD 3.5)
and 13.7 (SD 2.3). No significant differences in improve-
ment were observed between adopting and non-adopting
journals (mean difference  0.06 [95% CI: 2.5 to 2.4]).
For none of the individual items, significant differences
were found in improvement between adopting and non-
adopting journals.
Cohort studies vs case control studies. Between 2000
and 2004, the mean number of items reported in cohort
studies had changed from 12.4 (SD 3.0) to 14.4 (SD 2.8) vs
10.8 (SD 3.7) and 11.8 (SD 3.2) for case control studies, a
nonsignificant difference in improvement (1.1 items [95%
CI: 0.6 to 2.8]) although quality of reporting was higher
in cohort studies (mean difference  1.7 items [95% CI: 0.9
to 2.5]).
Except for item 11a (OR  0.3 [95% CI: 0.1 to 1.0]), no
significant differences were found in improvement of re-
porting quality for individual items between cohort and
case control studies.
Discussion. After publication of the STARD
statement, the quality of reporting of diagnostic
accuracy studies has slightly improved. It is un-
clear whether this small improvement is caused by
the publication of the STARD statement as we did
not find any differences in the reporting of the
items between adopting and non-adopting jour-
nals. This could alternatively be attributed to an
increasing awareness of authors, reviewers, and
editors of the importance of the quality of report-
ing of research articles.
One obvious explanation for the small improve-
ment in quality of reporting is the timing of the
post-STARD evaluation. Is it probably too early to
expect an improvement in the quality of reporting of
studies published in 2004, as these studies were pub-
lished only 1 to 2 years after the publication of the
STARD statement? Yet some items of the STARD
statement, such as recruitment period (item 14),
measures of statistical uncertainty for the estimates
of diagnostic accuracy (item 21), and presentation of
a flow diagram could easily have been included in
the manuscript. An improvement in the quality of
reporting of these items suggests that authors, re-
viewers, and editors have used the STARD state-
ment. Other items, such as reasons why participants
failed to undergo one of the tests (item 16) and meth-
ods and calculation of test reproducibility (items 13
and 24), are more difficult to satisfy retrospectively,
as these items concern the design of the study. Im-
provement in the quality of reporting of these items
would take more time.
In contrast, the quality of reporting of randomized
controlled trials (RCTs) published 2 years after the
publication of the CONSORT statement had im-
proved and the use of the CONSORT statement in
the editorial process was associated with improve-
ments in the quality of reporting.17 Some authors
suggested that knowledge of design principles of
RCTs and the effects of bias are better known now
compared to diagnostic accuracy studies and are rel-
atively simple and straightforward for readers to
appraise.18
Part of the improvement in the quality of report-
ing can also be attributed to measurement error. The
assessment of the 2004 articles took place 2 years
after the 2000 articles. To be sure that the reviewers
used the same criteria in the same way, we have
carried out a reproducibility study.19 Although the
overall reproducibility of the assessment of the qual-
ity of reporting using the STARD checklist was
found to be good, substantial disagreements were
found for some items, so any small improvement in
the quality of reporting of these items should be in-
terpreted with caution.19 The presentation of a flow
diagram, including the design of the study and the
flow of patients through the study, would be helpful
in improving the quality of reporting, as it explicitly
Figure 2. The percentage of articles published in 2000 and
2004 that present at least the indicated number of Stan-
dards for the Reporting of Diagnostic Accuracy studies
(STARD statement) items. The straight line represents the
articles published in 2000 and the dotted line represents
the articles published in 2004.
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clarifies items that caused most confusion among
reviewers.19
The absence of a significant difference between
studies published in adopting and non-adopting jour-
nals warrants discussion. As the STARD statement
is available to everyone, some authors and reviewers
may have used the STARD statement for their
manuscripts irrespective of the guidelines of the
journal of submission. In addition, the absence of a
difference could be explained by the way the
STARD statement was used within the editorial
process. We found a large variation in formula-
tions in the guidelines for authors in the adopting
journals, with regard to the clearness and strict-
ness of the use of the STARD statement. In jour-
nals with strict and clear guidelines, one would
expect better quality of reporting. We could not
analyze this effect on the quality of reporting, as
the numbers of articles published in each journal
were too small for such a comparison.
The STARD statement consists of 25 individual
items. Failure to report some items withholds in-
formation from the reader with regard to applica-
bility, but does not necessarily invalidate the
evidence. Poor reporting of other items, such as
the blinding of the readers of the tests (item 11),
description of the criteria for the tests (items 8 and
9), description of the study population (item 15),
and the number of included patients that under-
went both test(s) (item 16), may reflect biased re-
sults.20,21 Our study shows that these items were
poorly reported. This does not necessarily mean
that bias is present, but that the likelihood of bias
cannot be determined.
In general, the quality of reporting of cohort stud-
ies was better than in case control studies. It should
be emphasized that, in theory, case control studies
are also able to satisfy all individual items.
In our study, we selected journals that frequently
publish studies on diagnostic accuracy and had an
impact factor of at least 4. The quality of reporting of
diagnostic accuracy studies in journals with lower
impact factors showed similar results as our pre-
STARD evaluation.12,14 Therefore, the results of our
study can be generalized to journals with lower im-
pact factors. However, we expect that an improve-
ment in the quality of reporting may become
apparent first in journals with higher impact factors,
as they put higher demands on manuscripts than
journals with lower impact factors.
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